STOCK TITAN

Former CFO Peter Conley Adds 107,500 KNW Shares via Prestwick

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Know Labs, Inc. (KNW) reporting person Peter J. Conley, identified as a former Chief Financial Officer, acquired 107,500 shares of Common Stock on 07/31/2025 at a reported price of $0. After the transaction he beneficially owned 157,750 shares, held indirectly through Prestwick Associates LLC. The Form 4 discloses this insider acquisition and the form of ownership.

Positive

  • Insider acquisition: Peter J. Conley acquired 107,500 shares of Know Labs common stock.
  • Increased beneficial ownership: Total beneficial ownership reported as 157,750 shares indirectly via Prestwick Associates LLC.

Negative

  • None.

Insights

TL;DR: Insider acquired 107,500 KNW shares, raising indirect holdings to 157,750.

The Form 4 shows Peter J. Conley acquired 107,500 common shares on 07/31/2025 at a reported price of $0 and now beneficially owns 157,750 shares indirectly via Prestwick Associates LLC. This filing documents an insider purchase and the resulting indirect ownership level; the filing does not provide market context, transaction rationale, or valuation details.

TL;DR: Former CFO reports an indirect increase in ownership via Prestwick Associates LLC.

The reporting person is identified as a former Chief Financial Officer and disclosed an acquisition of 107,500 shares and indirect beneficial ownership of 157,750 shares through Prestwick Associates LLC. The Form 4 explicitly notes the ownership form and nature of indirect ownership; it does not include any contractual plan, amendment details, or explanatory narrative.

Insider Conley Peter J
Role Insider
Type Security Shares Price Value
Grant/Award Common Stock 107,500 $0.00 --
Holdings After Transaction: Common Stock — 157,750 shares (Indirect, Prestwick Associates LLC)
Footnotes (1)
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
X
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Conley Peter J

(Last) (First) (Middle)
619 WESTERN AVENUE
SUITE 610

(Street)
SEATTLE WA 98104

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
KNOW LABS, INC. [ KNW ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
Officer (give title below) X Other (specify below)
Former Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
07/31/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/31/2025 A 107,500 A $0 157,750 I Prestwick Associates LLC
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
/s/ Peter J. Conley 08/08/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Form 4 for Know Labs (KNW) report?

The Form 4 reports that Peter J. Conley acquired 107,500 shares of common stock on 07/31/2025 and beneficially owns 157,750 shares indirectly.

At what price were the KNW shares acquired by the reporting person?

The filing shows a reported price of $0 for the acquisition recorded on the Form 4.

How is the ownership held according to the Form 4 for KNW?

The filing indicates the beneficial ownership is held indirectly via Prestwick Associates LLC.

What is the reporting person’s relationship to Know Labs (KNW)?

The Form 4 identifies the reporting person, Peter J. Conley, as a former Chief Financial Officer of the issuer.

Does the Form 4 explain the reason for the transaction?

No. The Form 4 discloses the transaction details and ownership form but does not provide an explanation or rationale for the acquisition.
Know Labs

NYSE:KNW

View KNW Stock Overview

KNW Rankings

KNW Latest News

KNW Latest SEC Filings

KNW Stock Data

791.52M
6.23M
Scientific & Technical Instruments
Measuring & Controlling Devices, Nec
Link
United States
SEATTLE